Advertisement
UK markets close in 3 hours 11 minutes

  • FTSE 100

    8,098.30
    +57.92 (+0.72%)
     

  • FTSE 250

    19,731.80
    +12.43 (+0.06%)
     

  • AIM

    755.57
    +0.88 (+0.12%)
     

  • GBP/EUR

    1.1668
    +0.0024 (+0.20%)
     

  • GBP/USD

    1.2504
    +0.0042 (+0.34%)
     

  • Bitcoin GBP

    51,160.25
    -2,143.87 (-4.02%)
     

  • CMC Crypto 200

    1,355.76
    -26.81 (-1.94%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    83.15
    +0.34 (+0.41%)
     

  • GOLD FUTURES

    2,341.10
    +2.70 (+0.12%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,996.69
    -92.01 (-0.51%)
     

  • CAC 40

    8,022.56
    -69.30 (-0.86%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

Zacks Equity Research
·2-min read

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Thermo Fisher Scientific (TMO) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.

Thermo Fisher Scientific is one of 902 companies in the Medical group. The Medical group currently sits at #14 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. TMO is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for TMO's full-year earnings has moved 32.61% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

ADVERTISEMENT

According to our latest data, TMO has moved about 28.71% on a year-to-date basis. In comparison, Medical companies have returned an average of -2.24%. This shows that Thermo Fisher Scientific is outperforming its peers so far this year.

Breaking things down more, TMO is a member of the Medical - Instruments industry, which includes 97 individual companies and currently sits at #179 in the Zacks Industry Rank. On average, stocks in this group have gained 11.54% this year, meaning that TMO is performing better in terms of year-to-date returns.

Going forward, investors interested in Medical stocks should continue to pay close attention to TMO as it looks to continue its solid performance.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research